Recording: 1st EMBRN webinar 2025
1st EMBRN webinar took place on October 8, 2025. This event highlights exciting new research on mast cells and skin immunity. Thomas Plum was our keynote speaker
1st EMBRN webinar took place on October 8, 2025. This event highlights exciting new research on mast cells and skin immunity. Thomas Plum was our keynote speaker
This intensive mast cell training school is designed to provide young investigators (under 35 years old), with or without mast cell background, with the means to discover new targets for the regulation of mast cell function and to design preclinical and clinical studies to treat
Summary Chronic urticaria (CU) is a mast cell (MC)-dependent disease with limited therapeutic options. Current management strategies are directed at inhibiting IgE-mediated activation of MCs and antagonizing effects of released mediators. Due to the complexity and heterogeneity of CU and other MC diseases and mechanisms